Showing 8181-8190 of 9426 results for "".
- NYAM Academic Research Awards in Dermatology Program Accepting Applicationshttps://practicaldermatology.com/news/20141016-nyam_academic_research_awards_in_dermatology_program_accepting_applications/2459083/The application period is now open for the NYAM Academic Research Awards in dermatology program. Deadline for applications is December 15, 2014. The NYAM Academic Research Awards Program provides funding for residents and early-career dermatologists performing basic science or clinical research re
- Harvard Business Review Names Allergan's David E. I. Pyott a Top CEOhttps://practicaldermatology.com/news/20141015-harvard_business_review_names_allergans_david_e_i_pyott_a_top_ceo/2459084/David E.I. Pyott, Chairman of the Board and Chief Executive Officer of Allergan, Inc., has been ranked the 4th best-performing CEO in the world by the Harvard Business Review (HBR). Mr. Pyott was selected for this honor out of a total o
- New Data for Topical Nitric Oxide Nanoparticles: Evidence in Animal Model of EDhttps://practicaldermatology.com/news/20141014-new_data_for_topical_nitrous_oxide_nanoparticles_evidence_in_animal_model_of_ed/2459086/Topically applied nitric oxide-releasing nanoparticles (NO-NPs) induced spontaneous erections and increased basal ICP in an animal model of radical prostatectomy. According to findings published in The Journal o
- AmSpa Welcomes Cathy Christensen as Executive Director or Operations and Communicationshttps://practicaldermatology.com/news/20141009-amspa_welcomes_cathy_christensen_as_executive_director_or_operations_and_communications/2459089/Cathy Christensen, former editor of Skin Inc. magazine and conference director for the Face and Body events, is now Executive Director or Operations and Communications of AmpSpa. Christensen said, "I have been honored to have a role in serving the professional skin care industry's profes
- Researchers to Present Gigapixel Whole-Body Camera at OSA Annual Meetinghttps://practicaldermatology.com/news/20141008-researchers_to_present_gigapixel_whole-body_camera_at_osa_annual_meeting/2459091/A new “gigapixel whole-body photographic camera” may provide an option for tracking changes in potentially cancer skin lesions. Duke University researchers who developed the imaging technology will presenting it at the The Optical Society's (OSA) 98th Annual Meeting, Frontiers in Optics, Oct. 19-23
- Dermira Prices Initial Public Offeringhttps://practicaldermatology.com/news/20141003-dermira_prices_initial_public_offering/2459096/Dermira will price its initial public offering of 7,812,500 shares of common stock at a price to the public of 16 dollars per share. The shares are expected to begin trading on The NASDAQ Global Select Market on October 3, 2014 under the symbol DERM.Citigroup and Leerink Partners are acti
- Teledermatology App Teams Up with Dermatologistshttps://practicaldermatology.com/news/20141002-teledermatology_company_teams_up_with_dermatologists/2459098/A new teledermatology app is partnering with board- and state-certified dermatologists to assist patients with on-the-spot information regarding the detection and evaluation of skin disease in early stages. Having launched already in 13 states, Klara has partnered up with Dr. Mark Kaufmann, MD, Asso
- Ranbaxy Launches Absorica 25mg and 35mg Capsuleshttps://practicaldermatology.com/news/20141001-ranbaxy_launches_absorica_25mg_and_35mg_capsules/2459099/Ranbaxy Laboratories Inc., a wholly owned subsidiary of Ranbaxy Laboratories Limited, launched Absorica (isotretinoin) 25 mg and 35 mg capsules into the US healthcare market. Absorica, according to the company, has become the most prescribe
- Foamix Pharmaceuticals Ltd. Closes Initial Public Offeringhttps://practicaldermatology.com/news/20140924-foamix_pharmaceuticals_ltd_closes_initial_public_offering/2459104/Foamix Pharmaceuticals Ltd. Closes Initial Public Offering A total of 6.7 million ordinary shares were sold at a price to the public of $6.00 per share. In addition, Foamix has granted the underwriters a 30 day option to purchase up to 1,005,000 additional ordinary shares. The sha
- Cynosure Receives Expanded FDA Clearance to Market PicoSure for Treatment of Wrinkleshttps://practicaldermatology.com/news/20140924-cynosure_receives_expanded_fda_clearance_to_market_picosure_for_treatment_of_wrinkles/2459105/Cynosure, Inc. has received FDA 510(k) clearance to market its PicoSure Picosecond Laser Workstation for the treatment of wrinkles with the company's new disposable energy delivery system, the FOCUS lens array. In the fourth quarter of 2012, PicoSure recieve